Phase 1a/1b BGB-290 for Advanced Solid Tumors.

Clinical trial NCT02361723 · COMPLETED

Trial details

NCT number: NCT02361723
Sponsor: BeiGene
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

For Participants With Advanced Solid Tumors Failed With Previous Lines of Treatment

Start date: 2014-07-03
Primary completion: 2019-09-03
Enrollment: 101

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.